AR229260A1 - Procedimiento para preparar una composicion de materia que posee actividad citolitica contra virus y celulas procarioticas y eucarioticas - Google Patents

Procedimiento para preparar una composicion de materia que posee actividad citolitica contra virus y celulas procarioticas y eucarioticas

Info

Publication number
AR229260A1
AR229260A1 AR289004A AR28900482A AR229260A1 AR 229260 A1 AR229260 A1 AR 229260A1 AR 289004 A AR289004 A AR 289004A AR 28900482 A AR28900482 A AR 28900482A AR 229260 A1 AR229260 A1 AR 229260A1
Authority
AR
Argentina
Prior art keywords
procariotic
prepare
matter
procedure
composition
Prior art date
Application number
AR289004A
Other languages
English (en)
Spanish (es)
Original Assignee
Kiel Johnathan L
Everse Johannes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kiel Johnathan L, Everse Johannes filed Critical Kiel Johnathan L
Application granted granted Critical
Publication of AR229260A1 publication Critical patent/AR229260A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • A61K38/385Serum albumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/443Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/18Multi-enzyme systems
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004Glucose oxidase (1.1.3.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y111/00Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01Peroxidases (1.11.1)
    • C12Y111/01007Peroxidase (1.11.1.7), i.e. horseradish-peroxidase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AR289004A 1981-04-07 1982-04-05 Procedimiento para preparar una composicion de materia que posee actividad citolitica contra virus y celulas procarioticas y eucarioticas AR229260A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/251,694 US4486408A (en) 1981-04-07 1981-04-07 Insoluble crosslinked cytotoxic oxidase-peroxidase system

Publications (1)

Publication Number Publication Date
AR229260A1 true AR229260A1 (es) 1983-07-15

Family

ID=22953019

Family Applications (1)

Application Number Title Priority Date Filing Date
AR289004A AR229260A1 (es) 1981-04-07 1982-04-05 Procedimiento para preparar una composicion de materia que posee actividad citolitica contra virus y celulas procarioticas y eucarioticas

Country Status (13)

Country Link
US (1) US4486408A (en:Method)
EP (1) EP0062434B1 (en:Method)
JP (1) JPS57177694A (en:Method)
AR (1) AR229260A1 (en:Method)
AT (1) ATE15813T1 (en:Method)
AU (1) AU556620B2 (en:Method)
CA (1) CA1187791A (en:Method)
DE (1) DE3266476D1 (en:Method)
DK (1) DK155082A (en:Method)
IL (1) IL65382A (en:Method)
IN (1) IN156471B (en:Method)
NO (1) NO158004C (en:Method)
ZA (1) ZA821924B (en:Method)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0236610A1 (en) * 1986-03-13 1987-09-16 Laclede Professional Products, Inc. Enzymatic bandages and pads
US4576817A (en) * 1984-06-07 1986-03-18 Laclede Professional Products, Inc. Enzymatic bandages and pads
SE8500341L (sv) * 1985-01-24 1986-07-25 Pharmacia Ab Desinfektionssats samt sett for desinfektion
US4974929A (en) * 1987-09-22 1990-12-04 Baxter International, Inc. Fiber optical probe connector for physiologic measurement devices
AU4402589A (en) * 1988-09-28 1990-04-18 Ideon Corporation Combination enzyme immunotherapeutics
FR2646777B1 (fr) * 1989-05-12 1993-09-03 Bio Serae Lab Procede de preparation d'un produit particulaire antimicrobien, produit antimicrobien obtenu et applications
US5486360A (en) * 1993-04-22 1996-01-23 St. Joseph Health Centre Method of treating tumour cells using catalase
CA2150029A1 (en) * 1993-09-22 1995-03-30 Spencer H. Lin Immobilization of chemically cross-linked proteins on solid supports
US7192766B2 (en) * 2001-10-23 2007-03-20 Medtronic Minimed, Inc. Sensor containing molded solidified protein
WO2013006762A2 (en) * 2011-07-06 2013-01-10 The Regents Of The University Of California Multiple-enzyme nanocomplexes
KR20250004257A (ko) * 2022-04-13 2025-01-07 엑스옥세미스 인코퍼레이티드 고형 암을 치료하기 위한 조성물 및 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004979A (en) * 1968-03-29 1977-01-25 Agence Nationale De Valorisation De La Recherche (Anvar) Preparation of active proteins cross-linked to inactive proteins
US4178362A (en) * 1969-06-03 1979-12-11 Telec S.A. Enzymatic dentifrices
US3638558A (en) * 1970-03-26 1972-02-01 Burger King Corp Cooking apparatus for comestibles immersed in heated oil
JPS528795B2 (en:Method) * 1971-12-30 1977-03-11
DE2214442C3 (de) * 1972-03-24 1981-09-10 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Überführung von Glucose in Gluconsäure
DE2307904A1 (de) * 1973-02-17 1974-08-29 Hoechst Ag Verwendung von katalasefreien oder katalsearmen glucoseoxidase-praeparaten als zytostatikum fuer maligne zellen
DK146942C (da) * 1978-04-19 1984-07-30 Novo Industri As Fremgangsmaade til fremstilling af et immobiliseret enzymprodukt
DE2911192A1 (de) * 1979-03-22 1980-10-02 Boehringer Sohn Ingelheim Neuartiges immobilisiertes glucoseoxidase-katalasepraeparat und seine verwendung zur enzymatischen glucoseoxidation

Also Published As

Publication number Publication date
ZA821924B (en) 1983-04-27
EP0062434B1 (en) 1985-09-25
NO158004B (no) 1988-03-21
CA1187791A (en) 1985-05-28
AU556620B2 (en) 1986-11-13
NO821167L (no) 1982-10-08
DK155082A (da) 1982-10-08
NO158004C (no) 1988-06-29
DE3266476D1 (en) 1985-10-31
IN156471B (en:Method) 1985-08-10
AU8173982A (en) 1982-10-14
IL65382A0 (en) 1982-05-31
US4486408A (en) 1984-12-04
JPS57177694A (en) 1982-11-01
ATE15813T1 (de) 1985-10-15
IL65382A (en) 1986-04-29
EP0062434A1 (en) 1982-10-13

Similar Documents

Publication Publication Date Title
BR8206954A (pt) Composicao inseticida e acaricida e processo de tratamento fitossanitario de vegetais com o fim de lutar contra os seus destruidores
AR229260A1 (es) Procedimiento para preparar una composicion de materia que posee actividad citolitica contra virus y celulas procarioticas y eucarioticas
DE2861428D1 (en) Optically active compounds, process for their preparation, and their application in the protection of plants
ES554961A0 (es) Un procedimiento para proteger un electrodo de grafito contra la oxidacion y la erosion
ES524409A0 (es) Procedimiento para obtener una pelicula pasteurizable y encogible por la coccion
ES295745Y (es) Una jeringa para mezclar dos componentes
IT1179144B (it) Agente anti virale e procedimento per inibire la propagazione di un virus
FI792563A7 (fi) Vermikuliitti- suomujen ja jähmeiden osasmaisten aineiden yhdistelmiä.
MX152648A (es) Mejoras a metodo y aparato para la estabilizacion de una pasta dental que contiene carrageenina
AR240909A1 (es) Derivados de 2-(2'-alquilbenzoil) -1,3-ciclohexanodiona, composicion que los comprende y procedimiento para prepararlo"
ES504118A0 (es) Una instalacion para formar apilamientos de mercancias en piezas
ES502286A0 (es) Procedimiento para la preparacion de una mezcla de un este- roide anti-inflamatorio y un fluoro-cloro-hidrocarburo para ser utilizado como propulsor
AR229088A1 (es) Procedimiento para preparar nuevas aminopiperidinas que tienen una actividad anorexica
MX155844A (es) Procedimiento para estabilizar una solucion de peroxido de hidrogeno y composicion resultante
BR8204295A (pt) Preparacao de combustivel nuclear e reciclagem dos residuos
AR229048A1 (es) Compuesto de 1-benzoil-3-fenilpiridilurea insecticida,composicion que lo comprende y procedimiento para prepararlo
AR223928A1 (es) Una fibra spandex y procedimiento para prepararla
BR8406075A (pt) Eletrodo negativo para gerar neutrons e irradiador
AR228255A1 (es) Procedimiento para la produccion de una preparacion sinergistica que tiene una actividad analgesica y miotonolitica mejorada
AU550028B2 (en) Utilization of cellulosic and lignocellulosic materials
EP0003318A3 (en) Process for the inactivation of viruses and its application to the preparation of pharmaceutical compositions and to the preparing process of foodstuffs
AR220005A1 (es) Composicion para limpieza de dentaduras postizas y procedimiento para su preparacion
JPS5630923A (en) Method of removing or moderating contagion of herpes and medical composition proper to said method
DE2964881D1 (en) Parainfluenza virus vaccine and its preparation
AR223472A1 (es) Compuesto de 3-cloro,2,6-dinitro-4-trifluormetil-n-bencenamina sustituida,composicion que lo comprende y procedimiento para prepararlo